Dr Reddy's Laboratories today announced that it is terminating its global depositary shares (GDS) facility on July 8, 2001, and not on June 6 as announced earlier.
The change in the schedule is to permit the payment of newly declared dividend to the share holders prior to the termination of the GDS facility, the company said in a release.
Once the GDS facility is terminated, the American depository shares (ADS) will be issued automatically in lieu of the 17.89 lakh GDSs which are outstanding as of March 31, 2001.
Also Read
It may be recalled that the board of directors of the company, at their meeting held on May 30, had declared a dividend of 40 per cent for fiscal 2000-01. The company notified July 6 as the date of book closure.
The annual general meeting (AGM) of the company will be held in September. At present, Dr Reddy's is in the process of finalising its fiscal 2000-01 accounts as per the US GAAP (generally accepted accounting practices).
The company has to finalise its accounts as per US GAAP norms within six months after the closure of the financial year.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
